|Year : 2017 | Volume
| Issue : 3 | Page : 176-180
A pilot study for the evaluation of pcr as a diagnostic tool in patients with suspected dermatophytoses
Robin Sharma1, Samiksha Gupta1, Dinesh P Asati2, T Karuna1, Shashank Purwar1, Debasis Biswas1
1 Department of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
2 Department of Dermatology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India
|Date of Web Publication||11-May-2017|
Department of Microbiology, All India Institute of Medical Sciences, Saket Nagar, Bhopal - 462 024, Madhya Pradesh
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Context: The conventional diagnostic tools for dermatophytoses suffer from several limitations including low sensitivity, specificity, and long turn-around-time. Aims: The present study was, therefore, performed to evaluate the performance of a polymerase chain reaction (PCR)-based method for the diagnosis of this condition. Settings and Design: The study was conducted in the Dermatology outpatient department of a tertiary care teaching hospital in central India over a period of 3 months from July to September 2015. Materials and Methods: Forty participants, including 25 cases and 15 controls, were recruited in this observational study. Direct microscopy and fungal culture were performed from skin scrapings and nail clippings collected from the participants. PCR was also performed to amplify the chitin synthase 1 and internal transcribed spacer 2 genes from DNA samples extracted from the same clinical materials, using the method reported by Brillowska-Dabrowska et al. The diagnostic performance of fungal culture and PCR was compared using OpenEpi software. Results: We observed a significant male predominance among patients with dermatophytoses. The sensitivity of fungal culture and dermatophyte PCR to diagnose dermatophytoses was 24% and 48%, respectively, whereas the specificity of the two assays was 100% and 93.3%, respectively. The likelihood ratio of a positive PCR assay was 7.2 and the negative likelihood ratio was 0.5. PCR assay also delivered a significant shortening of the time-to-diagnosis, with the mean turn-around-time being 8 hours and 14 days for PCR and culture, respectively. Conclusion: This study, thus, highlights the potential merits of the dermatophyte PCR assay in achieving a rapid diagnosis of dermatophytoses and underscores its utility as a complementary test to improve the sensitivity of the conventional diagnostic tools for this condition, as well as to reliably differentiate this condition from other similar skin conditions.
Keywords: Dermatophytoses, dermatophyte PCR, fungal culture, Tinea
|How to cite this article:|
Sharma R, Gupta S, Asati DP, Karuna T, Purwar S, Biswas D. A pilot study for the evaluation of pcr as a diagnostic tool in patients with suspected dermatophytoses. Indian Dermatol Online J 2017;8:176-80
|How to cite this URL:|
Sharma R, Gupta S, Asati DP, Karuna T, Purwar S, Biswas D. A pilot study for the evaluation of pcr as a diagnostic tool in patients with suspected dermatophytoses. Indian Dermatol Online J [serial online] 2017 [cited 2019 Jul 17];8:176-80. Available from: http://www.idoj.in/text.asp?2017/8/3/176/206113
| Introduction|| |
Although the community prevalence of dermatophytoses is not known for certain, it constitutes a common cause of skin disease in India., The clinical presentation at times may have nonspecific manifestations such as itching, rash, erythema, pigmentation, alopecia, scaling, follicular papules, pustules, and nail discolouration, thereby making its diagnosis difficult. Differentiation of this condition from similar lesions in psoriasis, seborrheic dermatitis, eczema, superficial candidiasis, erythrasma, etc., is often challenging. Frequent use of topical corticosteroid creams further alters the clinical presentation by obscuring the signs of inflammation.
The conventional procedures used in the laboratory diagnosis of this condition include potassium hydroxide (KOH) mount examination of samples from skin, hair, and nail tissues; fungal culture; and phenotypic identification of recovered isolates. These methods suffer from the limitations of being less sensitive, time-consuming, and expertise-dependent. Dearth of competent mycology laboratories in many parts of the country further precludes a proper diagnostic work-up.
Polymerase chain reaction (PCR)-based diagnosis, though practiced in many infective conditions, has not yet been widely employed as a diagnostic tool. Optimization of PCR for dermatophytoses holds the promise of delivering a sensitive, specific, and quick diagnostic tool that is not skill-based. In view of this, the present pilot study was designed to evaluate the potential of a PCR-based method to aid the diagnosis of dermatophytic fungal infections and to compare the same with the diagnostic performance of fungal culture.
| Materials and Methods|| |
A total of 40 participants attending our dermatology outpatient department were recruited in this observational study over a period of 3 months from July to September 2015. They included 25 patients, who were clinically diagnosed as suffering from dermatophytoses based on the characteristic features of their presenting lesions such as the presence of annular, erythematous, itchy plaques; peripheral scaling; centrifugal spread; subungual debris; yellowish or greenish discoloration of nails; onycholysis; thickening of nail plate; onychoschizia; and total dystrophy of nails. The control group (n = 15), comprised participants in which the diagnosis of dermatophytoses was ruled out and an alternative clinical diagnosis could be arrived at. This group of controls included patients suffering from a diverse range of conditions such as seborrheic dermatitis, allergic reactions, lichen planus, annular psoriasis, and polymorphic light eruptions. Skin scrapings (n = 11) and nail clippings (n = 4) were also collected from the controls. The clinical diagnosis of both the cases and the controls was made by a dermatologist who was blinded to the outcomes of the laboratory tests. Dermatophytoses was ruled out in controls based on clinical presentation, confirmation of alternative diagnoses, and negative results on KOH and fungal culture. Patients with doubtful clinical diagnosis and those who had taken systemic or topical antifungals/antibiotics/steroids in the previous 2 weeks were excluded from the study. The cases and controls were recruited consecutively following their presentation in our dermatology outpatient department, subject to fulfilment of the inclusion and exclusion criteria.
The study protocol was approved by the institutional ethics committee, and the clinical samples were collected after obtaining proper informed consent. The clinical samples including skin scrapings (n = 26) and nail clippings (n = 14) were collected depending on the lesion involved. A part of each of these samples was used for KOH mount examination and fungal culture, whereas the remaining samples were used for fungal DNA extraction and dermatophyte PCR. Direct microscopy of the samples for the presence of fungal elements was performed by placing the sample onto a clean glass slide with a drop of 10% KOH. Fungal culture was performed by inoculation onto Sabouraud's dextrose agar (SDA) (HiMedia) and Dermatophyte test agar (DTA) (HiMedia) supplemented with antibiotics. The culture tubes were incubated at 25°C for 3–4 weeks, and the isolates were identified by examination of the cultural characteristics and microscopic morphology.
The genomic DNA was extracted from a part of the clinical samples using the dermatophyte PCR (Statens Serum Institut, SSI Diagnostica, Denmark) kit. In brief, DNA extraction was done from the clinical samples by a 2-step 10-min incubation of the sample in 100 μl of extraction buffer (60 mM sodium bicarbonate [NaHCO3], 250 mM potassium chloride (KCl), and 50 mM Tris (hydroxymethyl) aminomethane (Tris), pH 9.5) at 95°C and subsequent addition of 100 μl anti-inhibition buffer (2% bovine serum albumin). After vortex mixing, the DNA-containing solution was used for PCR. A conventional multiplex PCR was performed using two sets of primers aimed at: (a) chs1 chitin synthase 1 for detecting dermatophytes; and (b) its2 (internal transcribed spacer) for detecting Trychophyton rubrum. The primer sequences were, as reported by previous authors, viz. (a) 5'-GAAGAAGATTGTCGTTTGCATCGTCTC-3' and 5'-CTCGAGGTCAAAGCACGCCAGAG -3' for amplifying chitin synthase gene from all dermatophyte genomes, and (b) 5'-TCTTTGAACGCACATTGCGCC-3' and 5'-CGGTCCTGAGGGCGCTGAA-3' for amplifying its2 gene from T. rubrum genome., The PCR mix include 10 μl and 8.0 μl of PCR ready mix and primer mix, respectively, (both provided in working concentration by the manufacturer) and 2.0 μl of DNA template. The primer mix included an internal plasmid control that served as a template for the T. rubrum specific primers  The amplification was performed in a thermal cycler (Applied Biosciences) and the PCR conditions consisted of one initial cycle of denaturation for 5 min at 94°C and 45 cycles of 30 s at 94°C; 30 s at 60°C; 30 s of extension at 72°C; and a final extension of 3 min at 72°C. After the PCR, the amplicons were electrophoresed in a 2% agarose gel and stained with ethidium bromide.
For calculating the sample size, we considered a sensitivity of 44% for dermatophyte PCR test  and a prevalence of 20% for dermatophytic infections among patients presenting to our dermatology outpatient department (based on our hospital records). With these considerations and an error rate of 10%, the optimum sample size was found to be 24.4. Accordingly, this time-bound pilot study was conducted with the recruitment of 25 cases and 15 controls. Chi-square test was applied to ascertain if the proportion of categorical variables between the two groups was statistically significant or not. Independent sample t-test was performed to examine if the continuous variables were significantly different between the two groups. These tests of significance were performed using the Statistical Package for the Social Sciences (SPSS) Version 21.0. (IBM Corp, 2012). The performance characteristics of the diagnostic tools were calculated using OpenEpi software. P value of <0.05 was considered significant.
| Results|| |
We recruited two groups of participants in this study based on the clinical evaluation of their presenting lesions by a dermatologist. The first group, viz. the case group (n = 25) comprised of patients who were clinically diagnosed to be suffering from dermatophytoses. The second group (n = 15) comprised patients in whom dermatophytosis could be clinically ruled out based on the examination of the lesions, which was further corroborated by negative findings on microscopy and fungal culture.
The mean (±SD) age of the patients in the case group was 38 (±18) years, which was similar to the age of patients included in the control group (40 ± 15 years). However, the former group included a significantly higher proportion of males (73%), compared to the latter group (27%) (P = 0.005). The clinical characteristics and the nature of presenting lesion among the cases and controls are compared in [Table 1]. A representative sample of lesions observed among the recruited participants is depicted in [Figure 1].
|Table 1: Profile of presenting lesions and risk factors among recruited participants|
Click here to view
|Figure 1: Representative sample of presenting lesions observed in the recruited cases. (a) Annular, scaly lesions on the chest. (b) Erythematous, itchy plaque on the left shoulder. (c) Erythematous plaque in the groin with scaling. (d) Nail plate discoloration with subungual debris. (e) Partially scaly, annular lesions in the V region of the neck suggestive of tinea incognito due to topical steroid misuse|
Click here to view
We observed a sensitivity of 24% (6/25) for the samples positive for fungal culture, whereas the corresponding figure for dermatophyte PCR was 48% (12/25) positive samples. The specificity of the fungal culture and PCR assays were 100% and 93.3% (14/15 control samples were negative). The isolates recovered on fungal culture were identified as T. rubrum (n = 2), T. mentragophytes(n = 2), T. verrucosum (n = 1), and Epidermophyton floccosum (n = 1) based on microscopic and cultural characteristics. KOH mount examination was positive in 11 out of 25 cases (44%) and in none of the 15 controls. The likelihood ratio of a positive PCR assay was 7.2 and the negative likelihood ratio for PCR was 0.5. The performance characteristics of fungal culture and dermatophyte PCR assays are shown in [Table 2]. The PCR assay also delivered a significant shortening of the time-to-diagnosis, with the mean turn-around-time being 8 hours and 14 days for PCR and culture, respectively. A representative gel picture of the PCR amplicons is shown in [Figure 2].
|Table 2: Comparison of the performance characteristics of fungal culture and dermatophyte PCR assay|
Click here to view
|Figure 2: Agarose gel electrophoresis of PCR amplicons. Lane 1: PCR-negative sample showing 600 bp band for Internal Control only. Lanes 2 and 3: PCR-positive samples showing 366 bp (base pair) band, conserved across all dermatophytes (Pan-dermatophyte band). Lanes 4 and 5: PCR-positive samples showing 203 bp band, specific for Trichophyton rubrum. Lane 6: Positive Control for Pan-dermatophyte band. Lane 7: Positive Control for Trichophyton rubrum. Lane M: 100 bp DNA ladder|
Click here to view
Comparing the results of the culture and PCR techniques, we observed concordance between the two techniques in 60% (15/25) of the cases. In 10 patients (40%), PCR was positive for the presence of dermatophytes (chs1), whereas the culture results were negative. In 2 patients (8%), PCR results were negative, though fungal culture revealed growth of dermatophytes. However, 100% concordance was observed between the culture and PCR results for T. rubrum, with both the culture-positive samples yielding positive results in PCR for its2 gene.
| Discussion|| |
In this study, we evaluated the potential of PCR assays in diagnosing dermatophytosis directly from clinical specimens. We observed sensitivity and specificity of 48% and 93.3%, respectively, with the PCR assay, which made it appear as an attractive complementary test for the diagnosis of this condition.
Despite the obvious advantages associated with a PCR assay for dermatophytosis, evaluation of such an assay is often challenging due to the lack of an appropriate “gold standard.” Use of fungal culture as the standard and considering the results of the same for calculation of “true positives” and “false positives” is inappropriate because its suboptimal sensitivity leads to incorrectly low values of diagnostic specificity and positive predictive value for the PCR assay. Similarly, the use of microscopy results as gold standard is also unjustified owing to the nonspecificity of its findings. In view of this, we sought to evaluate the diagnostic performance of the PCR assay by recruiting a group of cases and controls on the basis of the clinical characteristics of their lesions. Consideration of clinical symptoms alone has been reported to result in misdiagnosis presumably in 50% of the cases. However, we surmise correct identification of the group of cases in our study because microscopic and/or cultural evidence of dermatophytosis was obtained in all our patients. On the other hand, the control group was selected on the basis of observing conclusive evidence of an alternative diagnosis. None of the controls were culture-positive for dermatophytic moulds. Thus, we evaluated the PCR assay, vis-a-vis other diagnostic modalities, based on the “realistic” approach of using clinical diagnostic criteria as the “gold standard.”
Though PCR assays have been evaluated in dermatophytosis since the last decade, most of the studies have focussed on species identification of dermatophyte isolates recovered on fungal culture. Studies evaluating the diagnostic performance of PCR assays directly on clinical samples have been relatively rare. Some of these studies have targeted the amplification of the Internal Transcribed Spacer (its2) and 18S rDNA regions, chitin synthase 1 gene, and large subunit of rDNA.,, Similar to our results, all authors have reported a significantly higher sensitivity for the dermatophyte PCR assay compared to fungal culture. However, to the best of our knowledge, no study has evaluated the diagnostic specificity of the PCR assay in clinically simulating dermatological conditions. The finding of specificity value of 93.3% in this pilot study suggests the successful use of this assay in ruling out the diagnosis of clinically similar nondermatophytic conditions. Despite efforts taken to minimize amplicon contamination, false positivity among controls could have resulted from cross-contamination occurring during DNA extraction.
We observed PCR- negative results in 33.3% (2/6) of culture-positive samples. The PCR results in these samples could be affected by the inhomogeneous distribution of fungal DNA in the clinical material. In addition, as observed by Gräser et al., the sensitivity of the PCR assays could be improved by the selective accumulation of fungal DNA during extraction with a simultaneous reduction of human DNA. In an absence of such a method for fungal DNA extraction, increasing the template volume could add to the fungal DNA available for amplification, and thus add to the sensitivity of the assay. Because we had used a template volume of 2 μl in the assay, we feel that by using higher template volume we might have been able to achieve higher diagnostic sensitivity.
We observed PCR positivity in 42.1 (8/19) of culture-negative patients. Though the reason for this observation remained unclear in a majority of the patients, we could elicit prior history of antifungal treatment in some of these patients. Use of topical and systemic antifungal is known to affect the viability of the fungal agents, although PCR results remain uninfluenced by the same.
Our study suffered from two major limitations. First, carrying out the study on a larger sample size, which was precluded by logistic constraints and study duration, could have added to the power of the study. Second, we observed a culture-positivity rate of only 24%, which is relatively lower than similar studies reported by other authors. Third, unlike previous authors, we did not evaluate the specificity of the PCR assay in the context of non dermatophytic fungal infections such as Alternaria, Aspergillus, Acremonium, Saccharomyces cerevisiae, and Scopulariopsis brevicaulis, etc. Further studies need to be undertaken to validate the findings of this pilot study in a larger sample of dermatophytic patients, with suitable controls involving patients suffering from nondermatophytic fungal infections. The cost of the PCR-based assay was found to be approximately Rs 500 per sample compared to Rs 100 per sample being the cost of KOH microscopy and fungal culture. Despite the added cost, the significant reduction in turn-around-time and obviation of the need for mycological expertise makes this molecular assay an attractive diagnostic proposition.
| Conclusion|| |
Direct PCR assay for the diagnosis of dermatophytosis is more sensitive than the conventional fungal culture. Thus, it can help in achieving a rapid diagnosis of dermatophytosis and also distinguish dermatophytic infections from nondermatophytic skin conditions with similar presentation.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Grills N, Grills C, Spelman T, Stoove M, Hellard M, El-Hayek C, et al
. Prevalence survey of dermatological conditions in mountainous north India. Int J Dermatol 2012;51:579-87.
Hanumanthappa H, Sarojini K, Shilpashree P, Muddapur SB. Clinicomycological study of 150 cases of dermatophytosis in a tertiary care hospital in South India. Indian J Dermatol 2012;57:322-3.
] [Full text]
Mandell GL, Bennett JE, Dolin R, Editors. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th
ed. Philadelphia: Elsevier; 2010. p. 3347.
Brillowska-Dabrowska A, Nielsen SS, Nielsen HV, Arendrup MC. Optimized 5-hour multiplex PCR test for the detection of tinea unguium: Performance in a routine PCR laboratory. Med Mycol 2010;48:828-31.
Brillowska-Dabrowska A, Saunte DM, Arendrup MC. Five-hour diagnosis of dermatophyte nail infections with specific detection of Trichophyton rubrum. J Clin Microbiol 2007;45:1200-4.
Spiliopoulou A, Bartzavali C, Jelastopulu E, Anastassiou ED, Christofidou M. Evaluation of a commercial PCR test for the diagnosis of dermatophyte nail infections. J Med Microbiol 2015;64:25-31.
Kondori N, Abrahomsson A-L, Ataollahy N, Wennerås C. Comparison of a new commercial test, Dermatophyte-PCR kit, with conventional methods for rapid detection and identification of Trichophyton rubrum in nail specimens. Med Mycol 2010;48:1005-8.
SPSS: IBM Corp. Released 2012. IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp.
Dean A, Sullivan K, Soe M. Openepi: Open Source Epidemiologic Statistics For Public Health, Version. Atlanta, GA: OpenEpi.com.
Nenoff P, Krüger C, Schaller J, Ginter-Hanselmayer G, Schulte-Beerbühl R, Tietz HJ. Mycology-an update Part 2: Dermatomycoses: Clinical picture and diagnostics. J Dtsch Dermatol Ges 2014;12:749-77.
Faergemann J, Baran R. Epidemiology, Clinical presentation and diagnosis of onychomycosis. Br J Dermatol 2003;149(Suppl 65):1-4.
Graser Y, Czaika V, Ohst T. Diagnostic PCR of dermatophytes - An overview. J Dtsch Dermatol Ges 2012;10:721-6.
Elavarashi E, Kindo AJ, Kalyani J. Optimization of PCR-RFLP Directly from the Skin and Nails in Cases of Dermatophytosis, Targeting the ITS and the 18S Ribosomal DNA Regions. J Clin Diagn Res 2013;7:646-51.
Garg J, Tilak R, Garg A, Prakash P, Gulati AK, Nath G. Rapid detection of dermatophytes from skin and hair. BMC Res Notes 2009;2:60-5.
Ebihara M, Makimura K, Sato K, Abe S, Tsuboi R. Molecular detection of dermatophytes and nondermatophytes in onychomycosis by nested polymerase chain reaction based on 28S ribosomal RNA gene sequences. Br J Dermatol 2009;161:1038-44.
Verrier J, Pronina M, Peter C, Bontems O, Pratti M, Salamin K, et al
. Identification of infectious agents in onychomycoses by PCR-terminal restriction fragment length polymorphism. J Clin Microbiol 2012;50:553-61.
[Figure 1], [Figure 2]
[Table 1], [Table 2]